Visit the CES website To access keynotes, sessions and product announcements. View our high-resolution image gallery and
download B-roll footage for television oritorial use . Check out this week’s news from CTA, including
CTA’s US Consumer Technology OneYear Industry Forecast , CES 2025 Green Grants, the CTA 2025
Global Innovation Scorecard, CES 2025 Open, and saint vincent and the grenadines email list 100000 contact leads new investments in Quantum Word Congress .
The International Consumer Electronics Show (CES) will return to Las Vegas, USA from January 6 to 9, 2026. Let us once again “DIVE IN”!
About CES ® :
The International Consumer Electronics Show (CES) is the world’s most influential technology event
and a touchstone for breakthrough technologies and global innovators.
This is where the world’s largest brands come to do business and meet new partners, and it is also where the most innovative leaders take the stage
Own and produc by the Consumer Technology Association (CTA ® ), CES is the show dicat to all
aspects of technology. The 2025 International Consumer Electronics Show (CES 2025) will be held in
Las Vegas, USA from January 7 to 10, 2025. Visit practical application of html CES.tech for more information and follow the latest
CES news on social .
About the Consumer Technology Association (CTA ®
As the largest technology trade association in North America, the Consumer Technology Association
(CTA) is the technology industry itself. Our members are the world’s leading innovators—from
startups to establish brands—creating more than 18 million American jobs.
The Consumer Technology Association (CTA) owns and produces
The International Consumer Electronics Show (CES ® ) – the world’s largest technology event. Please visit CTA.tech to learn more about us. Follow us: CTAtech .
Menarini Group and Insilico Micine have enter into calling list a second exclusive global licensing agreement for an AI-discover preclinical asset targeting a high unmet ne in oncology.
This is the second asset that Menarini Group has licens from Insilico Micine, discover through Insilico Micine’s generative AI platform, and is similar to a preclinical-stage KAT6 inhibitor (MEN2312) licens a year ago; this drug was fast-track into the clinic Visit the CES website.